Variability_NN of_IN Angina_NP Symptoms_NP and_CC the_DT Risk_NN of_IN Major_NP Ischemic_NP Heart_NP Disease_NP Events_NP Fiona_NP C._NP Lampe1_NP ,_, Peter_NP H._NP Whincup2_NP ,_, A._NP Gerald_NP Shaper1_NP ,_, S._NP Goya_NP Wannamethee1_NP ,_, Mary_NP Walker1_NP and_CC Shah_NP Ebrahim3_NP 1_CD Cardiovascular_NP Research_NP Unit_NP ,_, Department_NP of_IN Primary_NP Care_NP and_CC Population_NP Sciences_NPS ,_, Royal_NP Free_NP and_CC University_NP College_NP Medical_NP School_NP ,_, London_NP ,_, United_NP Kingdom_NP ._SENT 2_CD Department_NP of_IN Public_NP Health_NP Sciences_NPS ,_, St._NP Georges_NPS Hospital_NP Medical_NP School_NP ,_, London_NP ,_, United_NP Kingdom_NP ._SENT 3_CD Department_NP of_IN Social_NP Medicine_NP ,_, University_NP of_IN Bristol_NP ,_, Bristol_NP ,_, United_NP Kingdom_NP ._SENT ABSTRACT_JJ TOP_NP ABSTRACT_NP INTRODUCTION_NP MATERIALS_NP AND_CC METHODS_NP APPENDIX_NP Assessment_NP of_IN other_JJ ..._: Follow-up_NN for_IN mortality_NN and_CC ..._: Statistical_NP methods_NNS RESULTS_NP DISCUSSION_NP REFERENCES_NP Variability_NP of_IN angina_NN symptoms_NNS over_IN a_DT 5-year_JJ period_NN was_VBD examined_VBN in_IN a_DT prospective_JJ study_NN ,_, in_IN which_WDT 7,109_CD British_JJ middle-aged_JJ men_NNS completed_VBD two_CD chest_NN pain_NN questionnaires_NNS ,_, Q1_NP (_( 1978-1980_CD )_) and_CC Q5_NP (_( 1983-1985_CD )_) ,_, and_CC were_VBD classified_VBN as_IN having_VBG no_DT chest_NN pain_NN ,_, nonexertional_JJ chest_NN pain_NN ,_, or_CC angina_NN (_( Q_NP )_) (_( exertional_JJ chest_NN pain_NN )_) on_IN each_DT occasion_NN ._SENT Within_IN persons_NNS ,_, there_EX was_VBD considerable_JJ variability_NN in_IN response_NN to_TO the_DT chest_NN pain_NN questions_NNS at_IN Q1_NP and_CC Q5_NP ._SENT Angina_NN (_( Q_NP )_) persistence_NN showed_VBD marked_JJ associations_NNS with_IN previous_JJ myocardial_JJ infarction_NN ,_, diagnosed_VBN angina_NN ,_, electrocardiogram_NN ischemia_NN ,_, and_CC subsequent_JJ major_JJ ischemic_JJ heart_NN disease_NN events_NNS from_IN Q5_NP onward_RB ._SENT Compared_VBN with_IN men_NNS without_IN angina_NN (_( Q_NP )_) ,_, the_DT age-adjusted_JJ hazard_NN ratios_NNS were_VBD 1.5_CD (_( 95_CD %_NN confidence_NN interval_NN (_( CI_NP )_) :_: 1.1_CD ,_, 2.2_CD )_) for_IN angina_NN (_( Q_NP )_) at_IN Q1_NP only_RB ,_, 2.6_CD (_( 95_CD %_NN CI_NP :_: 2.1_CD ,_, 3.2_CD )_) for_IN angina_NN (_( Q_NP )_) at_IN Q5_NP only_RB ,_, and_CC 3.4_CD (_( 95_CD %_NN CI_NP :_: 2.8_CD ,_, 4.3_CD )_) for_IN angina_NN (_( Q_NP )_) on_IN both_DT occasions_NNS ._SENT For_IN men_NNS without_IN diagnosed_VBN ischemic_JJ heart_NN disease_NN ,_, for_IN whom_WP apparent_JJ remission_NN of_IN angina_NN (_( Q_NP )_) was_VBD particularly_RB frequent_JJ ,_, a_DT similar_JJ pattern_NN of_IN association_NN was_VBD found_VBN between_IN angina_NN (_( Q_NP )_) persistence_NN and_CC subsequent_JJ major_JJ events_NNS ._SENT In_IN middle-aged_JJ men_NNS ,_, exertional_JJ chest_NN pain_NN is_VBZ a_DT strong_JJ indicator_NN of_IN major_JJ coronary_JJ risk_NN but_CC frequently_RB appears_VBZ transient_JJ in_IN the_DT longer_JJR term_NN ._SENT Persistently_RB reported_VBN symptoms_NNS are_VBP associated_VBN with_IN severe_JJ disease_NN and_CC a_DT poor_JJ prognosis_NN ._SENT angina_NN pectoris_NN ;_: chest_NN pain_NN ;_: coronary_JJ disease_NN ;_: prospective_JJ studies_NNS ;_: questionnaires_NNS Abbreviations_NNS :_: angina_NN (_( Q_NP )_) ,_, exertional_JJ chest_NN pain_NN ;_: ECG_NP ,_, electrocardiogram_NN ;_: Q1_NP ,_, 1978-1980_CD questionnaire_NN ;_: Q5_NP ,_, 1983-1985_CD questionnaire_NN ;_: Q92_NP ,_, November_NP 1992_CD questionnaire_NN ._SENT INTRODUCTION_NN TOP_NP ABSTRACT_NP INTRODUCTION_NP MATERIALS_NP AND_CC METHODS_NP APPENDIX_NP Assessment_NP of_IN other_JJ ..._: Follow-up_NN for_IN mortality_NN and_CC ..._: Statistical_NP methods_NNS RESULTS_NP DISCUSSION_NP REFERENCES_NP In_IN epidemiologic_JJ studies_NNS and_CC surveys_NNS ,_, angina_NN is_VBZ identified_VBN most_RBS commonly_RB by_IN a_DT single_JJ administration_NN of_IN the_DT standard_JJ (_( 1_CD Go_NP )_) or_CC a_DT shortened_VBN version_NN (_( 2_CD Go_NP Go_NP Go_NP Go_NP -6_NP Go_NP )_) of_IN the_DT World_NP Health_NP Organization_NP (_( WHO_WP )_) (_( Rose_NP )_) questionnaire_NN ._SENT Several_JJ reports_NNS (_( 7_CD Go_NP Go_NP Go_NP -10_NP Go_NP )_) have_VBP highlighted_VBN the_DT substantial_JJ variability_NN of_IN a_DT person_NN 's_POS responses_NNS to_TO the_DT chest_NN pain_NN questionnaire_NN from_IN one_CD occasion_NN to_TO another_DT ._SENT How_WRB much_RB of_IN this_DT variability_NN is_VBZ due_JJ to_TO measurement_NN error_NN and_CC how_WRB much_RB is_VBZ a_DT feature_NN of_IN the_DT natural_JJ history_NN of_IN true_JJ ischemic_JJ pain_NN is_VBZ not_RB known_VBN ._SENT Certainly_RB this_DT variability_NN is_VBZ not_RB unique_JJ to_TO angina_NN ascertained_VBD using_VBG a_DT chest_NN pain_NN questionnaire_NN ,_, as_IN apparent_JJ remission_NN of_IN symptoms_NNS also_RB occurs_VBZ in_IN a_DT significant_JJ proportion_NN of_IN cases_NNS when_WRB angina_NN is_VBZ defined_VBN by_IN clinical_JJ assessment_NN (_( 11_CD Go_NP Go_NP Go_NP Go_NP Go_NP -16_NP Go_NP )_) ._SENT By_IN examining_VBG the_DT association_NN of_IN persistent_JJ and_CC variable_JJ angina_NN symptoms_NNS reported_VBD on_IN questionnaire_NN with_IN other_JJ indicators_NNS of_IN ischemic_JJ heart_NN disease_NN ,_, Rose_NP (_( 7_CD Go_NP )_) and_CC others_NNS (_( 10_CD Go_NP )_) have_VBP suggested_VBN that_DT persistence_NN of_IN angina_NN could_MD be_VB used_VBN to_TO grade_VB severity_NN of_IN disease_NN ._SENT However_RB ,_, to_TO our_PP$ knowledge_NN ,_, the_DT association_NN of_IN persistence_NN of_IN questionnaire-assessed_JJ chest_NN pain_NN with_IN subsequent_JJ long-term_JJ risk_NN of_IN a_DT major_JJ ischemic_JJ heart_NN disease_NN event_NN has_VBZ not_RB been_VBN described_VBN in_IN a_DT general_JJ population_NN study_NN ._SENT We_PP examined_VBD this_DT issue_NN using_VBG data_NNS from_IN two_CD questionnaires_NNS completed_VBN by_IN middle-aged_JJ men_NNS who_WP participated_VBD in_IN the_DT British_NP Regional_NP Heart_NP Study_NP (_( 17_NP Go_NP )_) ._SENT This_DT paper_NN describes_VBZ the_DT variability_NN associated_VBN with_IN elicited_VBN chest_NN pain_NN symptoms_NNS over_IN a_DT 5-year_JJ period_NN ,_, compares_VBZ the_DT characteristics_NNS of_IN men_NNS with_IN persistent_JJ and_CC variable_JJ angina_NN symptoms_NNS ,_, and_CC examines_VBZ the_DT effect_NN of_IN persistence_NN of_IN angina_NN on_IN ischemic_JJ heart_NN disease_NN outcome_NN ._SENT MATERIALS_NNS AND_CC METHODS_NP TOP_NP ABSTRACT_NP INTRODUCTION_NP MATERIALS_NP AND_CC METHODS_NP APPENDIX_NP Assessment_NP of_IN other_JJ ..._: Follow-up_NN for_IN mortality_NN and_CC ..._: Statistical_NP methods_NNS RESULTS_NP DISCUSSION_NP REFERENCES_NP The_DT British_NP Regional_NP Heart_NP Study_NP is_VBZ a_DT prospective_JJ study_NN of_IN 7,735_CD men_NNS ,_, aged_VBN 40-59_CD years_NNS at_IN entry_NN (_( 1978-1980_CD )_) ,_, who_WP were_VBD randomly_RB selected_VBN from_IN the_DT age-sex_JJ registers_NNS of_IN one_CD general_JJ practice_NN in_IN each_DT of_IN 24_CD British_JJ towns_NNS ._SENT The_DT criteria_NNS for_IN selecting_VBG the_DT towns_NNS ,_, the_DT general_JJ practices_NNS ,_, and_CC the_DT subjects_NNS have_VBP been_VBN reported_VBN elsewhere_RB (_( 17_CD Go_NP )_) ._SENT In_IN brief_NN ,_, the_DT 24_CD towns_NNS were_VBD chosen_VBN from_IN those_DT with_IN populations_NNS of_IN 50,000-100,000_CD ._SENT The_DT study_NN towns_NNS covered_VBD the_DT full_JJ range_NN of_IN mortality_NN from_IN cardiovascular_JJ disease_NN ,_, and_CC all_DT major_JJ geographic_JJ regions_NNS were_VBD included_VBN ._SENT The_DT social_JJ class_NN distribution_NN of_IN the_DT general_JJ practice_NN population_NN in_IN each_DT town_NN was_VBD required_VBN to_TO be_VB representative_JJ of_IN that_DT town_NN ._SENT The_DT initial_JJ screening_NN included_VBD physical_JJ measurements_NNS ,_, a_DT questionnaire_NN administered_VBN by_IN a_DT research_NN nurse_NN (_( Q1_NP )_) ,_, and_CC a_DT three-lead_JJ resting_JJ electrocardiogram_NN (_( ECG_NP )_) ._SENT The_DT average_JJ response_NN rate_NN was_VBD 78_CD percent_NN ._SENT The_DT men_NNS were_VBD followed_VBN from_IN screening_NN for_IN mortality_NN and_CC for_IN cardiovascular_JJ morbidity_NN through_IN their_PP$ general_JJ practices_NNS ._SENT In_IN addition_NN ,_, surviving_VBG men_NNS who_WP still_RB resided_VBD in_IN Britain_NP were_VBD sent_VBN an_DT additional_JJ self-administered_VBN questionnaire_NN on_IN the_DT fifth_JJ anniversary_NN of_IN their_PP$ baseline_JJ screening_NN (_( Q5_NP )_) and_CC in_IN November_NP 1992_CD (_( Q92_NP )_) ._SENT This_DT paper_NN describes_VBZ the_DT changes_NNS in_IN elicited_VBN chest_NN pain_NN symptoms_NNS over_IN the_DT 5-year_JJ period_NN from_IN Q1_NP to_TO Q5_NP and_CC the_DT association_NN of_IN chest_NN pain_NN persistence_NN with_IN subsequent_JJ ischemic_JJ heart_NN disease_NN outcome_NN ._SENT Assessment_NN of_IN chest_NN pain_NN at_IN Q1_NP and_CC Q5_NP At_IN Q1_NP and_CC Q5_NP ,_, subjects_NNS were_VBD classified_VBN into_IN one_CD of_IN three_CD chest_NN pain_NN categories_NNS according_VBG to_TO their_PP$ response_NN to_TO a_DT modified_JJ version_NN of_IN the_DT WHO_WP (_( Rose_NP )_) chest_NN pain_NN questionnaire_NN (_( 1_CD Go_NP )_) :_: 1_LS )_) no_DT chest_NN pain_NN ,_, 2_LS )_) nonexertional_JJ chest_NN pain_NN (_( defined_VBN as_IN chest_NN pain_NN not_RB brought_VBD on_RP by_IN walking_VBG )_) ,_, or_CC 3_LS )_) angina_NN (_( Q_NP )_) (_( defined_VBN as_IN chest_NN pain_NN brought_VBN on_IN either_CC by_IN walking_VBG uphill_JJ or_CC hurrying_VBG or_CC by_IN walking_VBG at_IN an_DT ordinary_JJ pace_NN on_IN the_DT level_NN (_( 2_CD Go_NP ,_, 3_CD Go_NP )_) )_) ._SENT The_DT (_( Q_NP )_) notation_NN is_VBZ used_VBN to_TO denote_VB angina_NN symptoms_NNS on_IN questionnaire_NN (_( 18_CD Go_NP )_) ._SENT Two_CD subdivisions_NNS of_IN angina_NN (_( Q_NP )_) were_VBD also_RB used_VBN ._SENT First_RB ,_, angina_NN (_( Q_NP )_) was_VBD classified_VBN as_IN "_`` definite_JJ angina_NN (_( Q_NP )_) "_'' if_IN four_CD additional_JJ criteria_NNS were_VBD fulfilled_VBN (_( the_DT subject_NN stopped_VBD or_CC slowed_VBD walking_VBG in_IN response_NN to_TO the_DT pain_NN ,_, the_DT pain_NN was_VBD relieved_VBN on_IN stopping_NN ,_, the_DT pain_NN was_VBD relieved_VBN within_IN 10_CD minutes_NNS ,_, and_CC the_DT site_NN of_IN pain_NN included_VBD the_DT sternum_NN or_CC left_VBD anterior_JJ chest_NN )_) and_CC as_IN "_`` possible_JJ angina_NN (_( Q_NP )_) "_`` if_IN no_DT more_JJR than_IN three_CD of_IN the_DT four_CD additional_JJ criteria_NNS were_VBD fulfilled_VBN ._SENT Second_RB ,_, angina_NN (_( Q_NP )_) was_VBD classified_VBN as_IN "_`` grade_VB I_PP angina_NN (_( Q_NP )_) "_`` if_IN pain_NN was_VBD brought_VBN on_IN only_RB by_IN walking_VBG uphill_JJ or_CC hurrying_VBG and_CC as_IN "_`` grade_NN II_CD angina_NN (_( Q_NP )_) "_`` if_IN pain_NN was_VBD brought_VBN on_IN by_IN walking_VBG at_IN an_DT ordinary_JJ pace_NN on_IN the_DT level_NN ._SENT The_DT chest_NN pain_NN questionnaire_NN ,_, details_NNS of_IN definitions_NNS ,_, and_CC missing_VBG values_NNS coding_VBG is_VBZ shown_VBN in_IN the_DT Appendix_NN ._SENT View_VB this_DT table_NN :_: APPENDIX_NN TOP_NP ABSTRACT_NP INTRODUCTION_NP MATERIALS_NP AND_CC METHODS_NP APPENDIX_NP Assessment_NP of_IN other_JJ ..._: Follow-up_NN for_IN mortality_NN and_CC ..._: Statistical_NP methods_NNS RESULTS_NP DISCUSSION_NP REFERENCES_NP The_DT Chest_NP Pain_NP Questionnaire_NP and_CC Definitions_NP of_IN Questionnaire-assessed_NP Angina_NP View_NP this_DT table_NN :_: View_VB this_DT table_NN :_: Assessment_NN of_IN other_JJ characteristics_NNS at_IN Q1_NP and_CC Q5_NP TOP_NP ABSTRACT_NP INTRODUCTION_NP MATERIALS_NP AND_CC METHODS_NP APPENDIX_NP Assessment_NP of_IN other_JJ ..._: Follow-up_NN for_IN mortality_NN and_CC ..._: Statistical_NP methods_NNS RESULTS_NP DISCUSSION_NP REFERENCES_NP Other_JJ symptoms_NNS ._SENT In_IN the_DT nurse-administered_JJ questionnaire_NN (_( Q1_NP )_) ,_, a_DT history_NN of_IN "_`` possible_JJ myocardial_JJ infarction_NN "_'' was_VBD defined_VBN as_IN severe_JJ chest_NN pain_NN lasting_VBG half_PDT an_DT hour_NN or_CC more_JJR and_CC situated_VBN in_IN the_DT sternum_NN or_CC left_VBD anterior_JJ chest_NN (_( 18_CD Go_NP )_) ._SENT In_IN the_DT mailed_VBN questionnaire_NN (_( Q5_NP )_) ,_, possible_JJ myocardial_JJ infarction_NN was_VBD defined_VBN as_IN a_DT severe_JJ pain_NN across_IN the_DT front_NN of_IN the_DT chest_NN lasting_VBG half_PDT an_DT hour_NN or_CC more_JJR ._SENT "_`` Breathlessness_NN "_'' was_VBD defined_VBN at_IN Q1_NP only_RB by_IN using_VBG a_DT shortened_VBN version_NN of_IN the_DT Medical_NP Research_NP Council_NP respiratory_JJ questionnaire_NN (_( United_NP Kingdom_NP )_) (_( 19_CD Go_NP )_) ._SENT "_`` Calf_NN pain_NN on_IN exertion_NN "_'' was_VBD also_RB defined_VBN at_IN Q1_NP only_RB with_IN a_DT shortened_VBN version_NN of_IN the_DT WHO_WP intermittent_JJ claudication_NN questionnaire_NN (_( 20_CD Go_NP )_) ._SENT Self-reported_JJ physician_NN diagnoses_NNS of_IN ischemic_JJ heart_NN disease_NN ._SENT At_IN Q1_NP and_CC Q5_NP ,_, subjects_NNS who_WP reported_VBD ever_RB having_VBG been_VBN told_VBN by_IN a_DT physician_NN that_IN they_PP had_VBD angina_NN ,_, myocardial_JJ infarction_NN (_( heart_NN attack_NN ,_, coronary_JJ thrombosis_NN )_) ,_, or_CC either_DT condition_NN were_VBD classified_VBN as_IN having_VBG recall_NN of_IN a_DT diagnosis_NN of_IN 1_CD )_) angina_NN ,_, 2_LS )_) myocardial_JJ infarction_NN ,_, or_CC 3_LS )_) ischemic_JJ heart_NN disease_NN (_( 21_CD Go_NP )_) ._SENT Risk_NN factors_NNS ._SENT Details_NNS of_IN baseline_JJ measurement_NN of_IN blood_NN pressure_NN ,_, serum_NN total_NN cholesterol_NN ,_, body_NN mass_NN index_NN (_( weight/height2_JJ )_) (_( 17_CD Go_NP )_) ,_, and_CC electrocardiographic_JJ abnormalities_NNS (_( 22_CD Go_NP )_) have_VBP been_VBN reported_VBN previously_RB ._SENT Smoking_NN status_NN (_( 17_CD Go_NP )_) and_CC level_NN of_IN physical_JJ activity_NN (_( 23_CD Go_NP )_) were_VBD ascertained_VBN from_IN the_DT baseline_JJ questionnaire_NN (_( Q1_NP )_) ._SENT Follow-up_NN for_IN mortality_NN and_CC morbidity_NN TOP_NN ABSTRACT_NP INTRODUCTION_NP MATERIALS_NP AND_CC METHODS_NP APPENDIX_NP Assessment_NP of_IN other_JJ ..._: Follow-up_NN for_IN mortality_NN and_CC ..._: Statistical_NP methods_NNS RESULTS_NP DISCUSSION_NP REFERENCES_NP The_DT established_JJ notification_NN (_( "_`` tagging_VBG "_'' )_) procedure_NN of_IN the_DT National_NP Health_NP Service_NP Central_NP Registers_NP in_IN Southport_NP (_( for_IN England_NP and_CC Wales_NP )_) and_CC Edinburgh_NP (_( for_IN Scotland_NP )_) was_VBD used_VBN for_IN notification_NN of_IN deaths_NNS ._SENT A_DT fatal_JJ ischemic_JJ heart_NN disease_NN event_NN was_VBD recorded_VBN if_IN the_DT underlying_VBG cause_NN given_VBN on_IN the_DT death_NN certificate_NN was_VBD codes_NNS 410-414_CD from_IN the_DT International_NP Classification_NP of_IN Diseases_NP ,_, Ninth_NP Revision_NP ._SENT Sudden_JJ death_NN for_IN which_WDT no_DT other_JJ cause_NN was_VBD apparent_JJ and_CC which_WDT had_VBD been_VBN certified_VBN as_RB due_JJ to_TO ischemic_JJ heart_NN disease_NN was_VBD included_VBN in_IN this_DT category_NN ._SENT Information_NN on_IN nonfatal_NN myocardial_JJ infarctions_NNS ,_, angina_NN diagnoses_NNS ,_, and_CC coronary_JJ artery_NN bypass_NN grafts_NNS was_VBD obtained_VBN from_IN biennial_JJ reviews_NNS of_IN each_DT subject_NN 's_POS general_JJ practice_NN medical_JJ records_NNS (_( including_VBG hospital_NN correspondence_NN )_) (_( 24_CD Go_NP )_) ._SENT A_DT nonfatal_NN myocardial_JJ infarction_NN was_VBD required_VBN to_TO be_VB associated_VBN with_IN at_IN least_JJS two_CD of_IN the_DT following_VBG features_NNS at_IN the_DT time_NN the_DT event_NN occurred_VBN :_: 1_LS )_) severe_JJ ,_, prolonged_JJ chest_NN pain_NN ;_: 2_LS )_) electrocardiographic_JJ evidence_NN of_IN myocardial_JJ infarction_NN ;_: and_CC 3_LS )_) cardiac_JJ enzyme_NN abnormalities_NNS ,_, with_IN survival_NN for_IN at_IN least_JJS 28_CD days_NNS (_( 25_CD Go_NP )_) ._SENT A_DT "_`` major_JJ ischemic_JJ heart_NN disease_NN event_NN "_'' was_VBD defined_VBN as_IN a_DT fatal_JJ ischemic_JJ heart_NN disease_NN event_NN or_CC a_DT nonfatal_NN myocardial_JJ infarction_NN ._SENT The_DT guidance_NN given_VBN for_IN notification_NN of_IN angina_NN from_IN the_DT medical_JJ record_NN review_NN was_VBD "_`` typical_JJ effort_NN or_CC stress-related_JJ pain_NN ,_, "_'' but_CC diagnoses_NNS were_VBD not_RB required_VBN to_TO conform_VB to_TO specific_JJ criteria_NNS (_( 26_CD Go_NP )_) ._SENT By_IN December_NP 31_CD ,_, 1995_CD ,_, 99_CD percent_NN of_IN the_DT 7,735_CD men_NNS initially_RB examined_VBD in_IN 1978-1980_CD had_VBD been_VBN followed_VBN up_RP for_IN mortality_NN and_CC morbidity_NN for_IN 15_CD years_NNS ._SENT The_DT remaining_VBG 1_CD percent_NN was_VBD lost_VBN to_TO follow-up_NN ._SENT Statistical_JJ methods_NNS TOP_JJ ABSTRACT_NP INTRODUCTION_NP MATERIALS_NP AND_CC METHODS_NP APPENDIX_NP Assessment_NP of_IN other_JJ ..._: Follow-up_NN for_IN mortality_NN and_CC ..._: Statistical_NP methods_NNS RESULTS_NP DISCUSSION_NP REFERENCES_NP The_DT association_NN of_IN chest_NN pain_NN at_IN Q1_NP with_IN chest_NN pain_NN at_IN Q5_NP was_VBD assessed_VBN for_IN surviving_VBG men_NNS who_WP completed_VBD both_DT questionnaires_NNS ._SENT To_TO compare_VB the_DT characteristics_NNS and_CC prognosis_NN of_IN persistent_JJ and_CC variable_JJ angina_NN ,_, we_PP divided_VBD the_DT men_NNS into_IN four_CD groups_NNS based_VBN on_IN their_PP$ angina_NN (_( Q_NP )_) status_NN at_IN Q1_NP and_CC Q5_NP ._SENT Cox_NP proportional_JJ hazards_NNS survival_NN analysis_NN (_( 27_CD Go_NP )_) ,_, with_IN adjustment_NN for_IN age_NN (_( as_IN a_DT continuous_JJ variable_NN )_) ,_, was_VBD used_VBN to_TO assess_VB the_DT effect_NN of_IN angina_NN (_( Q_NP )_) persistence_NN on_IN the_DT risk_NN of_IN a_DT major_JJ ischemic_JJ heart_NN disease_NN event_NN ;_: results_NNS were_VBD presented_VBN as_IN hazard_NN ratios_NNS (_( relative_JJ risks_NNS )_) with_IN 95_CD percent_NN confidence_NN intervals_NNS ._SENT The_DT start_NN of_IN follow-up_NN for_IN this_DT survival_NN analysis_NN was_VBD the_DT subject_NN 's_POS date_NN of_IN Q5_NP ,_, and_CC the_DT endpoint_NN of_IN interest_NN was_VBD the_DT first_JJ major_JJ ischemic_JJ heart_NN disease_NN event_NN occurring_VBG after_IN Q5_NP ._SENT If_IN no_DT event_NN occurred_VBD ,_, the_DT follow-up_NN time_NN was_VBD censored_VBN at_IN either_CC the_DT date_NN of_IN nonischemic_JJ heart_NN disease_NN death_NN or_CC the_DT final_JJ day_NN of_IN follow-up_NN (_( December_NP 31_CD ,_, 1995_CD )_) ,_, whichever_WDT was_VBD sooner_RBR ._SENT The_DT average_JJ length_NN of_IN follow-up_NN from_IN Q5_NP to_TO December_NP 1995_CD was_VBD 11.7_CD years_NNS (_( range_NN ,_, 10.5-12.9_CD years_NNS )_) ._SENT Survival_NN curves_NNS were_VBD constructed_VBN by_IN using_VBG the_DT Kaplan-Meier_NP technique_NN ._SENT Event_NN rates_NNS per_IN 1,000_CD per_IN year_NN were_VBD age_NN standardized_JJ by_IN using_VBG direct_JJ standardization_NN to_TO the_DT overall_JJ age_NN distribution_NN of_IN responders_NNS at_IN Q5_NP (_( average_JJ age_NN ,_, 55_CD years_NNS )_) ._SENT RESULTS_VBZ TOP_NP ABSTRACT_NP INTRODUCTION_NP MATERIALS_NP AND_CC METHODS_NP APPENDIX_NP Assessment_NP of_IN other_JJ ..._: Follow-up_NN for_IN mortality_NN and_CC ..._: Statistical_NP methods_NNS RESULTS_NP DISCUSSION_NP REFERENCES_NP By_IN the_DT fifth_JJ anniversary_NN of_IN baseline_JJ screening_NN ,_, 281_CD of_IN the_DT original_JJ 7,735_CD men_NNS had_VBD died_VBN and_CC 26_CD had_VBD emigrated_VBN ._SENT Of_IN the_DT remaining_VBG 7,428_CD men_NNS ,_, 7,275_CD (_( 98_CD percent_NN )_) responded_VBD to_TO Q5_NP ._SENT Chest_NN pain_NN status_NN was_VBD missing_VBG for_IN 1_CD man_NN at_IN Q1_NP and_CC for_IN 165_CD men_NNS at_IN Q5_NP ;_: these_DT men_NNS were_VBD excluded_VBN from_IN analysis_NN ._SENT Chest_NN pain_NN at_IN Q1_NP and_CC Q5_NP The_DT overall_JJ prevalence_NN of_IN angina_NN (_( Q_NP )_) was_VBD 7.8_CD percent_NN (_( 607/7,734_CD )_) at_IN Q1_NP and_CC 10.8_CD percent_NN (_( 768/7,110_CD )_) at_IN Q5_NP for_IN men_NNS of_IN a_DT mean_JJ age_NN of_IN 50.2_CD and_CC 55.1_CD years_NNS ,_, respectively_RB ._SENT Definite_JJ angina_NN (_( Q_NP )_) accounted_VBD for_IN 60.5_CD and_CC 57.7_CD percent_NN of_IN all_DT angina_NN (_( Q_NP )_) at_IN Q1_NP and_CC Q5_NP ,_, respectively_RB ._SENT The_DT proportion_NN of_IN angina_NN (_( Q_NP )_) classified_VBD as_IN grade_NN II_NP increased_VBD from_IN 15.7_CD percent_NN at_IN Q1_NP to_TO 22.3_CD percent_NN at_IN Q5_NP ._SENT The_DT increase_NN in_IN angina_NN prevalence_NN over_IN the_DT 5_CD years_NNS was_VBD accounted_VBN for_IN by_IN the_DT aging_NN of_IN the_DT cohort_NN (_( figure_NN 1_CD )_) ._SENT Age-specific_JJ prevalences_NNS of_IN definite_JJ angina_NN (_( Q_NP )_) and_CC grade_VB II_CD angina_NN (_( Q_NP )_) also_RB were_VBD similar_JJ between_IN Q1_NP and_CC Q5_NP ._SENT View_NN larger_JJR version_NN (_( 17K_NP )_) :_: FIGURE_NN 1_CD ._SENT Age-specific_JJ prevalence_NN of_IN angina_NN (_( Q_NP )_) at_IN Q1_NP and_CC Q5_NP among_IN middle-aged_JJ men_NNS in_IN the_DT British_NP Regional_NP Heart_NP Study_NP ,_, Great_NP Britain_NP ._SENT Angina_NN (_( Q_NP )_) ,_, exertional_JJ chest_NN pain_NN ;_: Q1_NP ,_, questionnaire_NN completed_VBN by_IN subjects_NNS in_IN 1978-1980_CD ;_: Q5_NP ,_, questionnaire_NN completed_VBN by_IN subjects_NNS in_IN 1983-1985_CD ._SENT Variability_NN of_IN chest_NN pain_NN between_IN Q1_NP and_CC Q5_NP Table_NP 1_CD shows_NNS the_DT association_NN between_IN chest_NN pain_NN status_NN at_IN Q1_NP and_CC chest_NN pain_NN status_NN at_IN Q5_NP for_IN the_DT 7,109_CD men_NNS who_WP completed_VBD both_DT questionnaires_NNS ._SENT Within_IN persons_NNS ,_, there_EX was_VBD considerable_JJ variability_NN in_IN response_NN to_TO the_DT chest_NN pain_NN questions_NNS over_IN the_DT 5-year_JJ period_NN ._SENT Of_IN the_DT men_NNS with_IN definite_JJ angina_NN (_( Q_NP )_) at_IN Q1_NP ,_, a_DT minority_NN (_( 39_CD percent_NN )_) also_RB had_VBD definite_JJ angina_NN (_( Q_NP )_) at_IN Q5_NP ,_, 22_CD percent_NN had_VBD possible_JJ angina_NN (_( Q_NP )_) at_IN Q5_NP ,_, and_CC the_DT remainder_NN reported_VBD nonexertional_JJ chest_NN pain_NN (_( 11_CD percent_NN )_) or_CC no_DT chest_NN pain_NN (_( 29_CD percent_NN )_) at_IN Q5_NP ._SENT Of_IN the_DT men_NNS with_IN possible_JJ angina_NN (_( Q_NP )_) at_IN Q1_NP ,_, 22_CD percent_NN remained_VBD in_IN this_DT category_NN 5_CD years_NNS later_RBR ,_, whereas_IN 25_CD percent_NN had_VBD definite_JJ angina_NN (_( Q_NP )_) ,_, 18_CD percent_NN had_VBD nonexertional_JJ chest_NN pain_NN ,_, and_CC 36_CD percent_NN had_VBD no_DT chest_NN pain_NN at_IN Q5_NP ._SENT When_WRB definite_JJ and_CC possible_JJ angina_NN were_VBD combined_VBN ,_, 55_CD percent_NN of_IN the_DT men_NNS with_IN angina_NN (_( Q_NP )_) at_IN Q1_NP also_RB had_VBD angina_NN (_( Q_NP )_) at_IN Q5_NP ,_, a_DT further_JJR 14_CD percent_NN had_VBD nonexertional_JJ chest_NN pain_NN ,_, and_CC 32_CD percent_NN reported_VBD no_DT chest_NN pain_NN ._SENT Of_IN all_DT men_NNS with_IN grade_NN II_CD angina_NN (_( Q_NP )_) at_IN Q1_NP ,_, only_RB 37_CD percent_NN continued_VBD to_TO report_VB grade_NN II_CD angina_NN (_( Q_NP )_) at_IN Q5_NP ;_: 34_CD percent_NN had_VBD grade_NN I_CD angina_NN (_( Q_NP )_) ,_, and_CC 20_CD percent_NN reported_VBD no_DT chest_NN pain_NN (_( table_NN 1_CD )_) ._SENT View_VB this_DT table_NN :_: TABLE_NN 1_CD ._SENT Association_NN between_IN chest_NN pain_NN status_NN at_IN Q1*_NP (_( 1978-1980_CD )_) and_CC at_IN Q5*_NP (_( 1983-1985_CD )_) in_IN middle-aged_JJ men_NNS ,_, using_VBG two_CD classifications_NNS of_IN chest_NN pain_NN ,_, British_NP Regional_NP Heart_NP Study_NP {_( dagger_NN }_) Association_NP of_IN persistent_JJ and_CC variable_JJ angina_NN (_( Q_NP )_) with_IN other_JJ factors_NNS The_DT 7,109_CD men_NNS who_WP responded_VBD to_TO both_DT Q1_NP and_CC Q5_NP were_VBD divided_VBN into_IN four_CD groups_NNS :_: those_DT reporting_VBG angina_NN (_( Q_NP )_) at_IN neither_DT Q1_NP nor_CC Q5_NP ,_, at_IN Q1_NP only_RB ,_, at_IN Q5_NP only_RB ,_, and_CC at_IN both_DT Q1_NP and_CC Q5_NP ._SENT These_DT four_CD groups_NNS were_VBD compared_VBN with_IN respect_NN to_TO other_JJ indicators_NNS of_IN ischemic_JJ heart_NN disease_NN (_( table_NN 2_CD )_) ._SENT Severe_JJ (_( grade_NN II_NP )_) angina_NN (_( Q_NP )_) ,_, definite_JJ angina_NN (_( Q_NP )_) ,_, a_DT history_NN of_IN possible_JJ myocardial_JJ infarction_NN ,_, and_CC subject_JJ recall_NN of_IN an_DT angina_NN or_CC ischemic_JJ heart_NN disease_NN diagnosis_NN at_IN either_DT Q1_NP or_CC Q5_NP showed_VBD very_RB marked_JJ relations_NNS with_IN angina_NN (_( Q_NP )_) persistence_NN ._SENT Men_NNS with_IN persistently_RB reported_VBN angina_NN (_( Q_NP )_) had_VBD considerably_RB higher_JJR prevalences_NNS of_IN these_DT characteristics_NNS than_IN those_DT men_NNS with_IN angina_NN (_( Q_NP )_) on_IN one_CD of_IN the_DT two_CD occasions_NNS only_RB ;_: in_IN turn_NN ,_, the_DT two_CD groups_NNS of_IN men_NNS with_IN angina_NN (_( Q_NP )_) on_IN only_RB one_CD occasion_NN had_VBD a_DT much_RB higher_JJR prevalence_NN of_IN these_DT characteristics_NNS than_IN men_NNS with_IN angina_NN (_( Q_NP )_) on_IN neither_DT occasion_NN ._SENT A_DT similar_JJ pattern_NN was_VBD found_VBN for_IN characteristics_NNS measured_VBN only_RB at_IN Q1_NP (_( ECG_NP ischemia_NN ,_, breathlessness_NN ,_, calf_NN pain_NN on_IN exertion_NN )_) ._SENT View_VB this_DT table_NN :_: TABLE_NN 2_CD ._SENT Association_NN of_IN angina_NN (Q)*_NN at_IN Q1*_NP (_( 1978-1980_CD )_) and/or_CC Q5*_NP (_( 1983-1985_CD )_) with_IN other_JJ evidence_NN of_IN ischemic_JJ heart_NN disease_NN and_CC with_IN cardiovascular_JJ risk_NN factors_NNS among_IN middle-aged_JJ men_NNS in_IN the_DT British_NP Regional_NP Heart_NP Study_NP Of_IN the_DT men_NNS who_WP had_VBD persistent_JJ angina_NN (_( Q_NP )_) ,_, almost_RB 70_CD percent_NN reported_VBD a_DT diagnosis_NN of_IN ischemic_JJ heart_NN disease_NN compared_VBN with_IN only_RB 34_CD percent_NN of_IN the_DT men_NNS with_IN angina_NN (_( Q_NP )_) on_IN one_CD occasion_NN and_CC 3_CD percent_NN of_IN the_DT men_NNS without_IN angina_NN (_( Q_NP )_) on_IN either_DT occasion_NN ._SENT Twenty-eight_JJ percent_NN of_IN the_DT men_NNS with_IN angina_NN (_( Q_NP )_) at_IN both_DT Q1_NP and_CC Q5_NP had_VBD a_DT medical_JJ record_NN of_IN angina_NN during_IN the_DT 5_CD years_NNS compared_VBN with_IN only_RB 5_CD percent_NN of_IN the_DT men_NNS with_IN angina_NN (_( Q_NP )_) at_IN Q1_JJ only_RB (_( table_NN 2_CD )_) ._SENT Looked_VBN at_IN from_IN a_DT different_JJ perspective_NN ,_, the_DT vast_JJ majority_NN (_( 81_CD percent_NN )_) of_IN the_DT 197_CD men_NNS with_IN angina_NN (_( Q_NP )_) and_CC recall_VB of_IN a_DT diagnosis_NN of_IN ischemic_JJ heart_NN disease_NN at_IN Q1_NP continued_VBD to_TO report_VB angina_NN (_( Q_NP )_) at_IN Q5_NP ,_, which_WDT compared_VBN with_IN only_RB 39_CD percent_NN of_IN the_DT 323_CD men_NNS with_IN angina_NN (_( Q_NP )_) but_CC no_DT diagnosis_NN of_IN ischemic_JJ heart_NN disease_NN at_IN Q1_NP ._SENT The_DT corresponding_JJ percentages_NNS for_IN persistence_NN of_IN definite_JJ angina_NN (_( Q_NP )_) were_VBD 53_CD percent_NN (_( 72/135_CD )_) and_CC 27_CD percent_NN (_( 47/174_CD )_) for_IN the_DT men_NNS with_IN and_CC without_IN diagnosed_VBN ischemic_JJ heart_NN disease_NN at_IN Q1_NP who_WP survived_VBD to_TO Q5_NP ._SENT Age_NN was_VBD also_RB strongly_RB associated_VBN with_IN angina_NN (_( Q_NP )_) persistence_NN ._SENT In_IN particular_JJ ,_, among_IN men_NNS with_IN angina_NN (_( Q_NP )_) at_IN Q1_NP ,_, the_DT likelihood_NN of_IN persistence_NN of_IN angina_NN (_( Q_NP )_) to_TO Q5_NP rose_VBD from_IN 42_CD percent_NN for_IN men_NNS aged_VBN 40-45_CD years_NNS to_TO 65_CD percent_NN for_IN men_NNS aged_VBN 55-59_CD years_NNS ._SENT Among_IN the_DT men_NNS without_IN diagnosed_VBN ischemic_JJ heart_NN disease_NN at_IN Q1_NP ,_, persistence_NN rates_NNS for_IN angina_NN (_( Q_NP )_) rose_VBD from_IN 36_CD to_TO 51_CD percent_NN across_IN the_DT four_CD age_NN groups_NNS ._SENT In_IN general_NN ,_, there_EX were_VBD less-marked_JJ differences_NNS in_IN the_DT baseline_JJ levels_NNS of_IN the_DT primary_JJ risk_NN factors_NNS between_IN those_DT reporting_NN variable_NN compared_VBN with_IN persistent_JJ angina_NN (_( Q_NP )_) (_( table_NN 2_CD )_) ._SENT The_DT exception_NN to_TO this_DT was_VBD reported_VBN physical_JJ activity_NN ,_, which_WDT had_VBD a_DT strong_JJ relation_NN with_IN angina_NN (_( Q_NP )_) persistence_NN ._SENT The_DT above_JJ analyses_NNS were_VBD based_VBN on_IN the_DT 7,109_CD men_NNS who_WP survived_VBD and_CC responded_VBD to_TO both_DT Q1_NP and_CC Q5_NP and_CC so_RB excluded_VBD the_DT 281_CD men_NNS who_WP died_VBD before_IN the_DT fifth_JJ anniversary_NN of_IN their_PP$ baseline_JJ screening_NN ._SENT Of_IN the_DT 607/7,734_CD men_NNS with_IN angina_NN (_( Q_NP )_) at_IN Q1_NP ,_, 57_CD (_( 9.4_CD percent_NN )_) died_VBD before_IN Q5_NP (_( age-adjusted_JJ hazard_NN ratio_NN =_SYM 2.4_CD ,_, 95_CD percent_NN confidence_NN interval_NN (_( CI_NP )_) :_: 1.8_CD ,_, 3.2_CD )_) ._SENT Note_NN that_IN among_IN those_DT 57_CD men_NNS ,_, the_DT baseline_JJ prevalences_NNS of_IN grade_NN II_CD angina_NN (_( Q_NP )_) ,_, possible_JJ myocardial_JJ infarction_NN ,_, ischemic_JJ heart_NN disease_NN diagnosis_NN ,_, ECG_NP ischemia_NN ,_, breathlessness_NN ,_, and_CC calf_NN pain_NN on_IN exertion_NN were_VBD higher_JJR than_IN for_IN all_DT four_CD groups_NNS in_IN table_NN 2_CD ,_, as_RB were_VBD the_DT levels_NNS of_IN cholesterol_NN ,_, systolic_JJ blood_NN pressure_NN ,_, and_CC smoking_NN ._SENT Association_NN of_IN persistent_JJ and_CC variable_JJ angina_NN (_( Q_NP )_) with_IN ischemic_JJ heart_NN disease_NN outcome_NN Overall_RB ,_, 825_CD of_IN the_DT 7,109_CD men_NNS experienced_VBD a_DT major_JJ ischemic_JJ heart_NN disease_NN event_NN in_IN the_DT period_NN from_IN Q5_NP until_IN December_NP 1995_CD ._SENT The_DT Kaplan-Meier_NP plot_NN for_IN the_DT four_CD angina_NN (_( Q_NP )_) categories_NNS is_VBZ shown_VBN in_IN figure_NN 2_CD ._SENT Persistently_RB reported_VBN angina_NN (_( Q_NP )_) was_VBD associated_VBN with_IN increased_VBN risk_NN compared_VBN with_IN angina_NN (_( Q_NP )_) present_NN on_IN one_CD occasion_NN only_RB ._SENT However_RB ,_, both_CC of_IN the_DT two_CD variable_JJ angina_NN (_( Q_NP )_) groups_NNS had_VBD an_DT increased_VBN risk_NN compared_VBN with_IN those_DT men_NNS without_IN angina_NN (_( Q_NP )_) ;_: of_IN these_DT two_CD groups_NNS ,_, the_DT men_NNS with_IN angina_NN (_( Q_NP )_) at_IN Q5_NP only_RB had_VBD a_DT considerably_RB worse_JJR prognosis_NN from_IN the_DT time_NN of_IN Q5_NP onward_RB than_IN those_DT men_NNS with_IN angina_NN (_( Q_NP )_) at_IN Q1_NP only_RB ._SENT View_NN larger_JJR version_NN (_( 18K_NP )_) :_: FIGURE_NN 2_CD ._SENT Proportion_NN of_IN middle-aged_JJ men_NNS free_JJ of_IN a_DT major_JJ ischemic_JJ heart_NN disease_NN event_NN (_( from_IN Q5_NP to_TO December_NP 1995_CD )_) ,_, by_IN angina_NN (_( Q_NP )_) status_NN at_IN Q1_NP and/or_CC Q5_NP ,_, British_NP Regional_NP Heart_NP Study_NP ,_, Great_NP Britain_NP ._SENT Angina_NN (_( Q_NP )_) ,_, exertional_JJ chest_NN pain_NN ;_: Q1_NP ,_, questionnaire_NN completed_VBN by_IN subjects_NNS in_IN 1978-1980_CD ;_: Q5_NP ,_, questionnaire_NN completed_VBN by_IN subjects_NNS in_IN 1983-1985_CD ._SENT Age-adjusted_JJ major_JJ ischemic_JJ heart_NN disease_NN event_NN rates_NNS and_CC hazard_NN ratios_NNS are_VBP given_VBN in_IN table_NN 3_CD ._SENT The_DT first_JJ set_NN of_IN columns_NNS shows_VBZ the_DT results_NNS for_IN the_DT whole_JJ sample_NN ._SENT Risks_NNS are_VBP given_VBN relative_JJ to_TO the_DT 6,105_CD men_NNS without_IN angina_NN (_( Q_NP )_) ._SENT In_IN fact_NN ,_, each_DT of_IN the_DT four_CD groups_NNS differed_VBD significantly_RB from_IN the_DT other_JJ three_CD with_IN respect_NN to_TO subsequent_JJ event_NN risk_NN ._SENT The_DT hazard_NN ratios_NNS tended_VBD to_TO be_VB largest_JJS in_IN early_JJ follow-up_NN and_CC to_TO attenuate_VB over_IN time_NN ._SENT Although_IN angina_NN (_( Q_NP )_) at_IN Q1_NP and_CC angina_NN (_( Q_NP )_) at_IN Q5_NP were_VBD independently_RB predictive_JJ of_IN subsequent_JJ event_NN risk_NN ,_, there_EX was_VBD no_DT interaction_NN (_( i.e._FW ,_, risks_NNS were_VBD multiplicative_JJ ._SENT )_) The_DT pattern_NN of_IN risk_NN was_VBD fairly_RB similar_JJ among_IN men_NNS with_IN uncomplicated_JJ angina_NN (_( Q_NP )_) at_IN Q5_NP (_( no_DT previous_JJ diagnosis_NN of_IN myocardial_JJ infarction_NN )_) and_CC among_IN those_DT without_IN a_DT diagnosis_NN of_IN ischemic_JJ heart_NN disease_NN at_IN Q5_NP (_( table_NN 3_CD )_) ._SENT However_RB ,_, in_IN these_DT latter_JJ two_CD subgroups_NNS ,_, risk_NN differences_NNS between_IN angina_NN (_( Q_NP )_) categories_NNS were_VBD reduced_VBN ,_, the_DT prevalence_NN of_IN persistent_JJ angina_NN (_( Q_NP )_) was_VBD low_JJ ,_, and_CC the_DT annual_JJ absolute_JJ risk_NN associated_VBN with_IN persistent_JJ angina_NN (_( Q_NP )_) was_VBD just_RB over_IN 2_CD percent_NN compared_VBN with_IN the_DT annual_JJ risk_NN of_IN 3.6_CD percent_NN for_IN persistent_JJ angina_NN (_( Q_NP )_) for_IN all_DT men_NNS ._SENT Further_JJR adjustment_NN for_IN other_JJ cardiovascular_JJ risk_NN factors_NNS (_( smoking_NN status_NN at_IN Q5_NP ,_, blood_NN pressure_NN ,_, total_JJ cholesterol_NN ,_, and_CC body_NN mass_NN index_NN at_IN Q1_NP )_) had_VBD no_DT material_NN effect_NN on_IN the_DT magnitude_NN of_IN hazard_NN ratios_NNS shown_VBN in_IN table_NN 3_CD ._SENT View_VB this_DT table_NN :_: TABLE_NN 3_CD ._SENT Risk_NN of_IN a_DT major_JJ ischemic_JJ heart_NN disease_NN event_NN from_IN Q5*_NP (_( 1983-1985_CD )_) to_TO December_NP 1995_CD ,_, according_VBG to_TO angina_NN (Q)*_NN at_IN Q1*_NP and/or_CC Q5_NP ,_, for_IN middle-aged_JJ men_NNS in_IN the_DT British_NP Regional_NP Heart_NP Study_NP Table_NP 4_CD presents_VBZ the_DT age-adjusted_JJ major_JJ ischemic_JJ heart_NN disease_NN event_NN rates_NNS from_IN Q5_NP onward_RB for_IN different_JJ combinations_NNS of_IN chest_NN pain_NN at_IN Q1_NP and_CC Q5_NP ._SENT The_DT top_JJ third_NN of_IN the_DT table_NN shows_VBZ that_IN "_`` nonexertional_JJ chest_NN pain_NN "_`` did_VBD not_RB differ_VB greatly_RB from_IN "_`` no_DT chest_NN pain_NN "_'' in_IN terms_NNS of_IN subsequent_JJ event_NN risk_NN ._SENT In_IN particular_JJ ,_, persistent_JJ nonexertional_JJ chest_NN pain_NN (_( present_JJ at_IN Q1_NP and_CC Q5_NP )_) was_VBD not_RB associated_VBN with_IN increased_VBN risk_NN ._SENT View_VB this_DT table_NN :_: TABLE_NN 4_CD ._SENT Age-adjusted_JJ event_NN rates*_NN of_IN major_JJ ischemic_JJ heart_NN disease_NN from_IN Q5_NP {_( dagger_NN }_) (_( 1983-1985_CD )_) to_TO December_NP 1995_CD ,_, by_IN chest_NN pain_NN classification_NN at_IN Q1_NP {_( dagger_NN }_) and_CC Q5_NP ,_, for_IN middle-aged_JJ men_NNS in_IN the_DT British_NP Regional_NP Heart_NP Study_NP The_DT second_JJ third_NN of_IN the_DT table_NN shows_VBZ the_DT effect_NN of_IN combinations_NNS of_IN possible_JJ angina_NN (_( Q_NP )_) and_CC definite_JJ angina_NN (_( Q_NP )_) on_IN subsequent_JJ event_NN risk_NN ;_: no_DT chest_NN pain_NN and_CC nonexertional_JJ chest_NN pain_NN were_VBD grouped_VBN together_RB ._SENT Overall_RB ,_, event_NN rates_NNS were_VBD similar_JJ for_IN definite_JJ and_CC possible_JJ angina_NN (_( Q_NP )_) ._SENT There_EX was_VBD little_JJ indication_NN that_IN persistent_JJ definite_JJ angina_NN (_( Q_NP )_) was_VBD associated_VBN with_IN a_DT higher_JJR risk_NN than_IN persistent_JJ possible_JJ angina_NN (_( Q_NP )_) ,_, or_CC definite_JJ angina_NN (_( Q_NP )_) on_IN one_CD occasion_NN and_CC possible_JJ angina_NN (_( Q_NP )_) on_IN the_DT other_JJ ,_, although_IN standard_JJ errors_NNS for_IN these_DT event_NN rates_NNS were_VBD large_JJ ._SENT However_RB ,_, men_NNS with_IN possible_JJ angina_NN (_( Q_NP )_) at_IN Q1_NP and_CC no_DT angina_NN (_( Q_NP )_) at_IN Q5_NP had_VBD a_DT much_RB lower_JJR event_NN rate_NN than_IN those_DT men_NNS with_IN definite_JJ angina_NN (_( Q_NP )_) at_IN Q1_NP and_CC no_DT angina_NN (_( Q_NP )_) at_IN Q5_NP ._SENT The_DT last_JJ third_NN of_IN the_DT table_NN shows_VBZ the_DT effect_NN of_IN combinations_NNS of_IN angina_NN grade_NN on_IN the_DT risk_NN of_IN a_DT major_JJ ischemic_JJ heart_NN disease_NN event_NN ._SENT Grade_NP II_NP angina_NN (_( Q_NP )_) present_NN on_IN either_DT occasion_NN tended_VBD to_TO increase_VB risk_NN compared_VBN with_IN grade_NN I_CD angina_NN (_( Q_NP )_) ._SENT Persistent_JJ grade_NN II_NP angina_NN (_( Q_NP )_) ,_, although_IN present_NN in_IN only_RB 27_CD men_NNS ,_, appeared_VBD to_TO be_VB associated_VBN with_IN exceptionally_RB high_JJ risk_NN ._SENT The_DT age-adjusted_JJ relative_JJ hazard_NN of_IN persistent_JJ grade_NN II_NP angina_NN (_( Q_NN )_) compared_VBN with_IN persistent_JJ grade_NN I_CD angina_NN (_( Q_NP )_) was_VBD 2.0_CD (_( 95_CD percent_NN CI_NP :_: 1.1_CD ,_, 3.7_CD )_) ._SENT DISCUSSION_NN TOP_NP ABSTRACT_NP INTRODUCTION_NP MATERIALS_NP AND_CC METHODS_NP APPENDIX_NP Assessment_NP of_IN other_JJ ..._: Follow-up_NN for_IN mortality_NN and_CC ..._: Statistical_NP methods_NNS RESULTS_NP DISCUSSION_NP REFERENCES_NP Over_IN a_DT 5-year_JJ period_NN ,_, there_EX was_VBD considerable_JJ variability_NN in_IN chest_NN pain_NN symptoms_NNS elicited_VBN by_IN questionnaire_NN among_IN middle-aged_JJ men_NNS in_IN the_DT general_JJ population_NN ._SENT Of_IN the_DT men_NNS who_WP survived_VBD for_IN the_DT 5_CD years_NNS ,_, those_DT with_IN persistent_JJ angina_NN (_( Q_NP )_) were_VBD much_RB more_RBR likely_JJ than_IN those_DT with_IN variable_JJ symptoms_NNS to_TO have_VB indicators_NNS of_IN severe_JJ disease_NN such_JJ as_IN evidence_NN of_IN myocardial_JJ infarction_NN ,_, a_DT physician_NN 's_POS diagnosis_NN of_IN ischemic_JJ heart_NN disease_NN ,_, and_CC an_DT abnormal_JJ resting_JJ ECG_NN ._SENT They_PP also_RB were_VBD more_RBR likely_JJ to_TO experience_VB a_DT subsequent_JJ major_JJ ischemic_JJ heart_NN disease_NN event_NN ._SENT Men_NNS with_IN angina_NN (_( Q_NP )_) on_IN one_CD occasion_NN only_RB had_VBD an_DT increased_VBN prevalence_NN of_IN other_JJ characteristics_NNS of_IN ischemic_JJ heart_NN disease_NN and_CC an_DT increased_VBN subsequent_JJ event_NN risk_NN compared_VBN with_IN men_NNS without_IN angina_NN (_( Q_NP )_) on_IN either_DT occasion_NN ._SENT Variability_NN of_IN angina_NN Variability_NN over_IN time_NN in_IN repeated_JJ response_NN to_TO the_DT WHO_WP (_( Rose_NP )_) chest_NN pain_NN questionnaire_NN has_VBZ been_VBN reported_VBN in_IN several_JJ studies_NNS (_( 7_CD Go_NP Go_NP Go_NP -10_NP Go_NP )_) ._SENT The_DT main_JJ difficulty_NN in_IN interpretation_NN is_VBZ determining_VBG how_WRB much_JJ of_IN the_DT variability_NN is_VBZ due_JJ to_TO measurement_NN error_NN (_( error_NN in_IN ascertainment_NN and_CC reporting_VBG of_IN symptoms_NNS )_) and_CC how_WRB much_RB is_VBZ due_JJ to_TO true_JJ changes_NNS in_IN symptom_NN status_NN ._SENT Furthermore_RB ,_, if_IN the_DT variability_NN does_VBZ reflect_VB true_JJ changes_NNS in_IN symptom_NN status_NN ,_, how_WRB much_RB is_VBZ attributable_JJ to_TO genuine_JJ changes_NNS in_IN ischemic_JJ pain_NN ?_SENT Ours_PP is_VBZ clearly_RB not_RB a_DT repeatability_NN study_NN ,_, because_IN there_EX was_VBD a_DT 5-year_JJ interval_NN between_IN Q1_NP and_CC Q5_NP ,_, during_IN which_WDT time_NN new_JJ cases_NNS of_IN angina_NN would_MD be_VB expected_VBN ._SENT In_IN addition_NN ,_, Q1_NP was_VBD administered_VBN by_IN a_DT research_NN nurse_NN ,_, whereas_IN Q5_NP was_VBD self-administered_VBN ._SENT When_WRB we_PP examined_VBD the_DT association_NN between_IN chest_NN pain_NN at_IN Q5_NP (_( 1983-1985_CD )_) and_CC chest_NN pain_NN elicited_VBN from_IN a_DT subsequent_JJ self-administered_VBN questionnaire_NN sent_VBN to_TO survivors_NNS in_IN November_NP 1992_CD (_( Q92_NP )_) ,_, we_PP found_VBD the_DT changes_NNS in_IN angina_NN (_( Q_NP )_) status_NN between_IN these_DT two_CD occasions_NNS (_( 8_CD years_NNS apart_RB )_) to_TO be_VB somewhat_RB lower_JJR :_: the_DT percentages_NNS of_IN men_NNS converting_VBG from_IN positive_JJ angina_NN (_( Q_NP )_) at_IN Q5_NP to_TO negative_JJ at_IN Q92_NP were_VBD 47_CD percent_NN for_IN definite_JJ angina_NN (_( Q_NP )_) and_CC 37_CD percent_NN for_IN all_DT angina_NN (_( Q_NP )_) ._SENT These_DT percentages_NNS compared_VBN with_IN corresponding_JJ conversion_NN rates_NNS of_IN 61_CD and_CC 45_CD percent_NN from_IN Q1_NP to_TO Q5_NP and_CC 59_CD and_CC 50_CD percent_NN from_IN Q1_NP to_TO Q92_NP ._SENT However_RB ,_, men_NNS were_VBD younger_JJR at_IN Q1_NP ,_, which_WDT also_RB may_MD have_VB contributed_VBN to_TO the_DT greater_JJR variability_NN ._SENT Studies_NNS with_IN yearly_JJ intervals_NNS between_IN repeat_NN administrations_NNS have_VBP found_VBN variability_NN of_IN a_DT similar_JJ magnitude_NN ,_, with_IN 40-60_CD percent_NN of_IN WHO_WP (_( Rose_NP )_) angina-positive_JJ men_NNS converting_VBG to_TO angina_NN negative_JJ a_DT year_NN later_RBR (_( 7_CD Go_NP ,_, 8_CD Go_NP ,_, 10_NP Go_NP )_) ._SENT In_IN their_PP$ repeatability_NN study_NN ,_, Lipid_NP Research_NP Study_NP investigators_NNS performed_VBD the_DT majority_NN of_IN repeated_JJ interviews_NNS on_IN the_DT same_JJ day_NN and_CC found_VBD much_RB higher_JJR estimates_NNS of_IN consistency_NN than_IN in_IN an_DT annual_JJ study_NN ;_: their_PP$ results_NNS were_VBD presented_VBN as_IN kappa_NN statistics_NNS ,_, and_CC the_DT values_NNS for_IN the_DT standard_JJ Rose_NP classification_NN for_IN men_NNS were_VBD approximately_RB 0.7_CD (_( 9_CD Go_NP )_) ._SENT This_DT suggests_VBZ that_IN the_DT Rose_NP questionnaire_NN is_VBZ not_RB an_DT inherently_RB unreliable_JJ instrument_NN ._SENT The_DT fact_NN that_IN apparent_JJ remission_NN of_IN symptoms_NNS also_RB has_VBZ been_VBN documented_VBN in_IN a_DT significant_JJ proportion_NN of_IN patients_NNS in_IN studies_NNS that_WDT used_VBD more_JJR stringent_JJ clinical_JJ definitions_NNS of_IN angina_NN (_( 11_CD Go_NP Go_NP Go_NP Go_NP Go_NP -16_NP Go_NP )_) also_RB suggests_VBZ that_IN symptom_NN variability_NN is_VBZ not_RB simply_RB a_DT feature_NN of_IN response_NN to_TO a_DT chest_NN pain_NN questionnaire_NN ._SENT Of_IN men_NNS with_IN new_JJ ,_, uncomplicated_JJ angina_NN defined_VBN by_IN the_DT structured_JJ clinical_JJ assessment_NN of_IN two_CD cardiologists_NNS in_IN Framingham_NP ,_, Massachusetts_NP ,_, up_RB to_TO one_CD third_NN had_VBD a_DT remission_NN in_IN symptoms_NNS of_IN at_IN least_JJS 2_CD years_NNS '_POS duration_NN (_( 11_CD Go_NP ,_, 12_NP Go_NP )_) ._SENT Furthermore_RB ,_, in_IN both_CC our_PP$ study_NN and_CC the_DT Atherosclerosis_NN Risk_NN in_IN Communities_NNS (_( ARIC_NP )_) study_NN (_( 10_CD Go_NP )_) ,_, discordant_JJ answers_NNS to_TO the_DT latter_JJ questions_NNS on_IN the_DT WHO_WP questionnaire_NN (_( which_WDT deal_VBP with_IN specific_JJ characteristics_NNS of_IN exertional_JJ chest_NN pain_NN )_) did_VBD not_RB fully_RB explain_VB the_DT variability_NN ,_, because_IN the_DT majority_NN of_IN the_DT subjects_NNS who_WP moved_VBD from_IN definite_JJ angina_NN (_( Q_NP )_) positive_JJ to_TO negative_JJ reported_VBN either_CC no_DT chest_NN pain_NN or_CC nonexertional_JJ chest_NN pain_NN on_IN the_DT secondoccasion_NN ._SENT Angina_NN persistence_NN and_CC prognosis_NN Previous_JJ studies_NNS have_VBP found_VBN a_DT strong_JJ association_NN of_IN persistence_NN of_IN angina_NN with_IN previous_JJ and_CC interim_JJ myocardial_JJ infarction_NN (_( 9_CD Go_NP ,_, 10_NP Go_NP )_) ECG_NP abnormality_NN (_( 7_CD Go_NP )_) and_CC use_VB of_IN chest_NN pain_NN medications_NNS (_( 9_CD Go_NP ,_, 10_NP Go_NP )_) ,_, although_IN the_DT association_NN with_IN carotid_JJ wall_NN thickness_NN (_( by_IN ultrasound_NN )_) was_VBD not_RB so_RB marked_JJ (_( 10_CD Go_NP )_) ._SENT We_PP have_VBP demonstrated_VBN a_DT strong_JJ association_NN between_IN angina_NN (_( Q_NP )_) persistence_NN and_CC subsequent_JJ long-term_JJ major_JJ event_NN risk--a_NN relation_NN suggested_VBN for_IN clinical_JJ angina_NN in_IN the_DT Framingham_NP study_NN (_( 11_CD Go_NP )_) ._SENT Although_IN there_EX was_VBD a_DT clear_JJ pattern_NN of_IN increasing_VBG risk_NN according_VBG to_TO whether_IN angina_NN (_( Q_NP )_) was_VBD present_JJ on_IN no_DT ,_, one_CD ,_, or_CC two_CD occasions_NNS ,_, men_NNS with_IN angina_NN (_( Q_NP )_) at_IN Q5_NP only_RB had_VBD a_DT worse_JJR prognosis_NN (_( from_IN the_DT time_NN of_IN Q5_NP )_) than_IN those_DT with_IN angina_NN (_( Q_NP )_) at_IN Q1_NP only_RB ._SENT The_DT former_JJ group_NN most_RBS likely_RB included_VBN a_DT substantial_JJ proportion_NN of_IN men_NNS who_WP had_VBD new_JJ angina_NN at_IN Q5_NP rather_RB than_IN "_`` variable_JJ "_'' symptoms_NNS ._SENT Unlike_IN the_DT two_CD groups_NNS with_IN angina_NN (_( Q_NP )_) at_IN Q1_NP ,_, these_DT men_NNS were_VBD not_RB required_VBN to_TO have_VB survived_VBN for_IN 5_CD years_NNS with_IN angina_NN (_( Q_NP )_) in_IN order_NN to_TO be_VB included_VBN in_IN the_DT analysis_NN ,_, and_CC they_PP had_VBD a_DT high_JJ risk_NN from_IN the_DT time_NN of_IN Q5_NP onward_RB ,_, particularly_RB in_IN the_DT short_JJ term_NN (_( figure_NN 2_CD )_) ._SENT We_PP previously_RB noted_VBD that_IN the_DT relative_JJ risk_NN associated_VBN with_IN angina_NN (_( Q_NP )_) falls_VBZ substantially_RB with_IN increasing_VBG length_NN of_IN follow-up_NN from_IN the_DT original_JJ assessment_NN (_( 28_CD Go_NP )_) ._SENT This_DT attenuation_NN in_IN relative_JJ risk_NN over_IN time_NN is_VBZ likely_JJ to_TO reflect_VB the_DT variability_NN of_IN angina_NN (_( Q_NP )_) during_IN follow-up_NN ._SENT Of_IN particular_JJ interest_NN is_VBZ the_DT marked_JJ contrast_NN in_IN prognosis_NN between_IN men_NNS with_IN angina_NN (_( Q_NP )_) at_IN both_DT Q1_NP and_CC Q5_NP and_CC men_NNS with_IN angina_NN (_( Q_NP )_) at_IN Q1_NP only_RB ,_, as_IN this_DT represents_VBZ a_DT comparison_NN of_IN persistent_JJ versus_CC seemingly_RB "_`` transient_JJ "_'' angina_NN ._SENT There_EX was_VBD a_DT twofold_JJ difference_NN in_IN subsequent_JJ event_NN risk_NN between_IN these_DT two_CD groups_NNS ._SENT Remission_NN of_IN angina_NN symptoms_NNS If_IN true_JJ angina_NN remission_NN is_VBZ a_DT contributory_JJ factor_NN to_TO conversion_NN from_IN positive_JJ to_TO negative_JJ angina_NN status_NN ,_, what_WP are_VBP the_DT mechanisms_NNS by_IN which_WDT this_DT conversion_NN could_MD occur_VB ?_SENT Development_NN of_IN collateral_NN circulation_NN for_IN ischemic_JJ areas_NNS has_VBZ been_VBN postulated_VBN ,_, as_RB has_VBZ the_DT occurrence_NN of_IN an_DT interim_JJ myocardial_JJ infarction_NN ,_, destroying_VBG the_DT ischemic_JJ area_NN and_CC thus_RB alleviating_VBG pain_NN ._SENT In_IN common_JJ with_IN other_JJ studies_NNS (_( 10_CD Go_NP Go_NP -12_NP Go_NP )_) ,_, we_PP found_VBD no_DT evidence_NN for_IN the_DT latter_JJ theory_NN ,_, as_IN interim_JJ infarction_NN was_VBD more_RBR likely_JJ in_IN men_NNS with_IN persistent_JJ angina_NN than_IN in_IN those_DT with_IN remission_NN of_IN symptoms_NNS ._SENT Another_DT possible_JJ explanation_NN is_VBZ a_DT reduction_NN in_IN oxygen_NN demand_NN :_: that_WDT is_VBZ ,_, the_DT subject_NN avoids_VBZ exertion_NN to_TO a_DT level_NN that_WDT would_MD cause_VB pain_NN ._SENT In_IN that_DT case_NN ,_, physical_JJ inactivity_NN would_MD be_VB expected_VBN to_TO be_VB associated_VBN with_IN reported_VBN symptom_NN remission_NN ._SENT In_IN our_PP$ study_NN ,_, the_DT opposite_JJ relation_NN was_VBD found_VBN (_( table_NN 2_CD )_) ._SENT Effective_JJ treatment_NN may_MD contribute_VB to_TO apparent_JJ symptom_NN remission_NN ._SENT However_RB ,_, of_IN those_DT men_NNS with_IN angina_NN (_( Q_NP )_) at_IN Q1_NP ,_, rates_NNS of_IN antihypertensive_NN ,_, lipid-lowering_NN ,_, and_CC analgesic_JJ medication_NN use_NN (_( this_DT included_VBN nitrates_NNS not_RB coded_VBN separately_RB at_IN Q1_NP )_) were_VBD higher_JJR for_IN those_DT with_IN persistent_JJ angina_NN (_( Q_NP )_) than_IN for_IN those_DT who_WP no_DT longer_RBR reported_JJ angina_NN (_( Q_NP )_) at_IN Q5_NP ._SENT Even_RB in_IN the_DT subgroup_NN of_IN men_NNS with_IN angina_NN (_( Q_NP )_) and_CC recall_VB of_IN a_DT diagnosis_NN of_IN ischemic_JJ heart_NN disease_NN at_IN Q1_NP ,_, there_EX was_VBD evidence_NN for_IN only_RB a_DT possible_JJ influence_NN of_IN coronary_JJ artery_NN bypass_NN graft_NN on_IN symptom_NN remission_NN at_IN Q5--medical_JJ treatments_NNS ,_, physical_JJ inactivity_NN ,_, and_CC interim_JJ infarction_NN showed_VBD no_DT association_NN with_IN reported_VBN angina_NN (_( Q_NP )_) remission_NN ._SENT Inadequate_JJ control_NN for_IN disease_NN severity_NN is_VBZ the_DT primary_JJ difficulty_NN of_IN assessing_VBG the_DT association_NN of_IN factors_NNS such_JJ as_IN physical_JJ inactivity_NN and_CC treatment_NN with_IN remission_NN of_IN symptoms_NNS in_IN an_DT epidemiologic_JJ study_NN ._SENT In_IN our_PP$ study_NN ,_, rather_RB than_IN these_DT factors_NNS being_VBG predictive_JJ of_IN symptom_NN remission_NN ,_, they_PP tended_VBD to_TO be_VB associated_VBN with_IN symptom_NN persistence_NN ,_, suggesting_VBG that_IN in_IN unselected_JJ middle-aged_JJ men_NNS in_IN the_DT population_NN who_WP survive_VBP for_IN repeated_JJ assessments_NNS ,_, angina_NN (_( Q_NP )_) persistence_NN is_VBZ primarily_RB a_DT marker_NN of_IN disease_NN severity_NN or_CC of_IN the_DT likelihood_NN of_IN genuine_JJ disease_NN ._SENT The_DT rate_NN of_IN apparent_JJ remission_NN of_IN angina_NN (_( Q_NP )_) from_IN Q1_NP to_TO Q5_NP was_VBD highest_RBS for_IN younger_JJR men_NNS and_CC was_VBD particularly_RB high_JJ for_IN men_NNS without_IN a_DT diagnosis_NN of_IN ischemic_JJ heart_NN disease_NN at_IN Q1_NP (_( 61_CD percent_NN )_) ._SENT Of_IN the_DT 363_CD men_NNS with_IN angina_NN (_( Q_NP )_) but_CC no_DT diagnosis_NN at_IN Q1_NP ,_, 6_CD percent_NN died_VBN before_IN Q5_NP ,_, 34_CD percent_NN survived_VBN and_CC had_VBD persistent_JJ angina_NN (_( Q_NP )_) ,_, and_CC 55_CD percent_NN survived_VBD and_CC did_VBD not_RB have_VB angina_NN (_( Q_NP )_) at_IN Q5_NP (_( the_DT remaining_VBG 5_CD percent_NN were_VBD nonresponders_NNS )_) ._SENT In_IN the_DT absence_NN of_IN an_DT adequate_JJ "_`` gold_JJ standard_NN "_'' for_IN angina_NN ,_, it_PP is_VBZ impossible_JJ to_TO estimate_VB what_WP proportion_NN of_IN these_DT surviving_VBG men_NNS with_IN transient_JJ angina_NN (_( Q_NP )_) but_CC no_DT diagnosis_NN at_IN Q1_NP had_VBD genuine_JJ ischemic_JJ pain_NN ._SENT Very_RB few_JJ of_IN them_PP (_( 3_CD percent_NN )_) acquired_VBD an_DT angina_NN diagnosis_NN from_IN Q1_NP to_TO Q5_NP ,_, and_CC there_EX was_VBD only_RB a_DT small-to-moderate_JJ increase_NN in_IN their_PP$ subsequent_JJ major_JJ event_NN risk_NN that_WDT was_VBD of_IN borderline_JJ statistical_JJ significance_NN ,_, suggesting_VBG that_IN a_DT different_JJ cause_NN of_IN pain_NN was_VBD possible_JJ for_IN a_DT significant_JJ proportion_NN ._SENT A_DT marked_JJ association_NN between_IN the_DT primary_JJ cardiovascular_JJ risk_NN factors_NNS and_CC symptom_NN persistence_NN was_VBD not_RB found_VBN in_IN this_DT or_CC other_JJ studies_NNS (_( 10_CD Go_NP ,_, 11_NP Go_NP )_) ._SENT Of_IN the_DT men_NNS with_IN angina_NN (_( Q_NP )_) at_IN Q1_NP who_WP survived_VBD to_TO Q5_NP ,_, levels_NNS of_IN total_JJ cholesterol_NN ,_, blood_NN pressure_NN ,_, body_NN mass_NN index_NN ,_, and_CC smoking_NN were_VBD marginally_RB but_CC not_RB significantly_RB higher_JJR among_IN the_DT 285_CD men_NNS whose_WP$ angina_NN (_( Q_NP )_) persisted_VBD to_TO Q5_NP compared_VBN with_IN the_DT 236_CD men_NNS without_IN angina_NN (_( Q_NP )_) at_IN Q5_NP (_( table_NN 2_CD )_) ._SENT Comparison_NN with_IN variability_NN over_IN time_NN of_IN other_JJ questionnaire-assessed_JJ measures_NNS The_DT chest_NN pain_NN questionnaire_NN used_VBN in_IN our_PP$ study_NN was_VBD phrased_VBN to_TO ask_VB about_IN current_JJ symptoms_NNS (_( "_`` Do_VBP you_PP ever_RB have_VBP any_DT pain_NN or_CC discomfort_NN in_IN your_PP$ chest_NN ?_SENT "_'' )_) ._SENT It_PP is_VBZ interesting_JJ to_TO compare_VB the_DT variability_NN apparent_JJ in_IN subsequent_JJ administrations_NNS of_IN the_DT chest_NN pain_NN questionnaire_NN with_IN that_DT in_IN the_DT answers_NNS to_TO other_JJ questions_NNS that_WDT should_MD not_RB ,_, if_IN answered_VBN correctly_RB ,_, change_NN from_IN positive_JJ on_IN one_CD occasion_NN to_TO negative_JJ on_IN a_DT subsequent_JJ occasion_NN ._SENT For_IN subject_JJ recall_NN of_IN ever_RB having_VBG had_VBD a_DT physician_NN diagnosis_NN of_IN a_DT 